Cargando…
The impact of tobacco smoking on treatment choice and efficacy in inflammatory bowel disease
Smoking significantly increases the risk of developing and worsens Crohn’s disease (CD), yet protects against the development and reduces the severity of ulcerative colitis. It is less clear whether smoking impacts the efficacy of therapeutics in inflammatory bowel disease (IBD). We review the liter...
Autores principales: | Nicolaides, Steven, Vasudevan, Abhinav, Long, Tony, van Langenberg, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100381/ https://www.ncbi.nlm.nih.gov/pubmed/33040518 http://dx.doi.org/10.5217/ir.2020.00008 |
Ejemplares similares
-
Inflammatory bowel disease and superior mesenteric artery thromboembolism
por: Nicolaides, Steven, et al.
Publicado: (2020) -
Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?
por: Vasudevan, Abhinav, et al.
Publicado: (2017) -
Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy
por: Con, Danny, et al.
Publicado: (2022) -
Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease
por: Bohra, Anuj, et al.
Publicado: (2022) -
Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability
por: Bohra, Anuj, et al.
Publicado: (2020)